
ILARIS 150 mg/ml, solution for injection bottle, 1 ml
Active ingredients: Canakinumab
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ILARIS 150 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 1 ml
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br><br>- Arthrite juvénile idiopathique systémique, en respectant certaines conditions<br>-Arthrite goutteuse, en respectant certaines conditions<br>- Syndromes de fièvres périodiques auto-inflammatoires (Syndromes périodiques associés à la cryopyrine, Syndrome périodique associé au récepteur du facteur de nécrose tumorale , Syndrome de l'hyperimmunoglobulinémie D/déficit en mévalonate kinase Fièvre méditerranéenne familiale), en respectant certaines conditions.<br>- Maladie de Still, en respectant certaines conditions.<br>- Arthrite goutteuse, en respectant certaines conditions<br>- Maladie de Still de l'adulte ; JOURNAL OFFICIEL ; 04/04/18
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Nov 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69541570CIP73008951CIP133400930089514Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CANAKINUMABsolution | 150 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.